Innodata Inc vs Novartis AG — how do they compare? Innodata Inc trades at $63.24 (market cap $2.05B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 144.1× Innodata Inc's market cap, and Novartis AG pays a 3.07% dividend while Innodata Inc pays none. Which is the better fit depends on your goals.
| INOD | NVS | |
|---|---|---|
Market Cap | $2.05B | $295.37B |
Sector | Technology | Health |
52-Week High | $121.50 | $168.62 |
52-Week Low | $34.45 | $119.31 |
Enterprise Value | $1.80B | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →